Bronchiectasis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
*A recent US study demonstrated a marked increased prevalence in older populations varying from 4.2/100,000 adults aged 18–34 years to 271.8/100,000 older than 75 years.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | *A recent US study demonstrated a marked increased prevalence in older populations varying from 4.2/100,000 adults aged 18–34 years to 271.8/100,000 older than 75 years.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
*Substantial socioeconomic cost is associated with frequent use of primary and secondary healthcare resources.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | *Substantial socioeconomic cost is associated with frequent use of primary and secondary healthcare resources.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
*A US epidemiological study of bronchiectasis-associated hospitalizations from 1993 to 2006 demonstrated an average annual hospitalization rate of 16.5/100 000 population with a significant annual increase of 2.4% in men and 3.0% in women.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | *A US epidemiological study of bronchiectasis-associated hospitalizations from 1993 to 2006 demonstrated an average annual hospitalization rate of 16.5/100,000 population with a significant annual increase of 2.4% in men and 3.0% in women.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
*Bronchiectasis often goes unrecognized or is misdiagnosed as asthma or chronic obstructive pulmonary disease (COPD), leading to an underestimated prevalence.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | *Bronchiectasis often goes unrecognized or is misdiagnosed as asthma or chronic obstructive pulmonary disease (COPD), leading to an underestimated prevalence.<ref name="pmid23728208">{{cite journal| author=McDonnell MJ, Ward C, Lordan JL, Rutherford RM| title=Non-cystic fibrosis bronchiectasis. | journal=QJM | year= 2013 | volume= 106 | issue= 8 | pages= 709-15 | pmid=23728208 | doi=10.1093/qjmed/hct109 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23728208 }} </ref> | ||
* Before antibiotics, the symptoms on bronchiectasis began in the patient's first decade of life. In developed countries, the age of onset has move to adulthood (except those with cysts fibrosis) | * Before antibiotics, the symptoms on bronchiectasis began in the patient's first decade of life. In developed countries, the age of onset has move to adulthood (except those with cysts fibrosis) | ||
Revision as of 18:03, 24 June 2015
|
Bronchiectasis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bronchiectasis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Bronchiectasis epidemiology and demographics |
|
Risk calculators and risk factors for Bronchiectasis epidemiology and demographics |
Overview
Bronchiectasis affects extremes of age in certain indigenous populations. It is difficult to estimate the prevalence because it is often misdiagnosed.
Bronchiectasis Epidemiology and Demographics
- There is no known association of bronchiectasis and a particular race.
- Bronchiectasis predominantly affect extremes of age with a slight female preponderance.[1] The women that are infected with primary Mycobacterium avium complex MAC) tend to be slender, caucasian, and older than 60 years. It is given the name of Lady Windermere syndrome which is named after a character in a novel by Oscar Wilde.
- Very high prevalence has been described in certain indigenous populations such as Alaskan natives with 10-20/1000 children affected.[1]
- A recent US study demonstrated a marked increased prevalence in older populations varying from 4.2/100,000 adults aged 18–34 years to 271.8/100,000 older than 75 years.[1]
- Substantial socioeconomic cost is associated with frequent use of primary and secondary healthcare resources.[1]
- A US epidemiological study of bronchiectasis-associated hospitalizations from 1993 to 2006 demonstrated an average annual hospitalization rate of 16.5/100,000 population with a significant annual increase of 2.4% in men and 3.0% in women.[1]
- Bronchiectasis often goes unrecognized or is misdiagnosed as asthma or chronic obstructive pulmonary disease (COPD), leading to an underestimated prevalence.[1]
- Before antibiotics, the symptoms on bronchiectasis began in the patient's first decade of life. In developed countries, the age of onset has move to adulthood (except those with cysts fibrosis)